Abstract |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic with millions of human infections. One limitation to the evaluation of potential therapies and vaccines to inhibit SARS-CoV-2 infection and ameliorate disease is the lack of susceptible small animals in large numbers. Commercially available laboratory strains of mice are not readily infected by SARS-CoV-2 because of species-specific differences in their angiotensin-converting enzyme 2 (ACE2) receptors. Here, we transduced replication-defective adenoviruses encoding human ACE2 via intranasal administration into BALB/c mice and established receptor expression in lung tissues. hACE2-transduced mice were productively infected with SARS-CoV-2, and this resulted in high viral titers in the lung, lung pathology, and weight loss. Passive transfer of a neutralizing monoclonal antibody reduced viral burden in the lung and mitigated inflammation and weight loss. The development of an accessible mouse model of SARS-CoV-2 infection and pathogenesis will expedite the testing and deployment of therapeutics and vaccines.
|
Authors | Ahmed O Hassan, James Brett Case, Emma S Winkler, Larissa B Thackray, Natasha M Kafai, Adam L Bailey, Broc T McCune, Julie M Fox, Rita E Chen, Wafaa B Alsoussi, Jackson S Turner, Aaron J Schmitz, Tingting Lei, Swathi Shrihari, Shamus P Keeler, Daved H Fremont, Suellen Greco, Paul B McCray Jr, Stanley Perlman, Michael J Holtzman, Ali H Ellebedy, Michael S Diamond |
Journal | Cell
(Cell)
Vol. 182
Issue 3
Pg. 744-753.e4
(08 06 2020)
ISSN: 1097-4172 [Electronic] United States |
PMID | 32553273
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Neutralizing
- Antibodies, Viral
- Peptidyl-Dipeptidase A
- ACE2 protein, human
- Ace2 protein, mouse
- Angiotensin-Converting Enzyme 2
|
Topics |
- Angiotensin-Converting Enzyme 2
- Animals
- Antibodies, Monoclonal
(therapeutic use)
- Antibodies, Neutralizing
(therapeutic use)
- Antibodies, Viral
(therapeutic use)
- Betacoronavirus
(immunology)
- COVID-19
- Chlorocebus aethiops
- Coronavirus Infections
(therapy, virology)
- Disease Models, Animal
- Female
- HEK293 Cells
- Humans
- Immunization, Passive
(methods)
- Lung
(metabolism, virology)
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Inbred DBA
- Mice, Knockout
- Pandemics
- Peptidyl-Dipeptidase A
(genetics, metabolism)
- Pneumonia, Viral
(therapy, virology)
- SARS-CoV-2
- Transduction, Genetic
- Vero Cells
- Viral Load
(immunology)
|